Quick Answer
ROCKWELL MEDICAL, INC. reported Research And Development Expense of $0.00 for the year ending 2025.
- ROCKWELL MEDICAL, INC. showed a decrease of -100.0% in Research And Development Expense from 2024 to 2025.
- This data is from ROCKWELL MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2009 to 2025), ROCKWELL MEDICAL, INC.'s Research And Development Expense has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $19.0 thousand | Fiscal year 2023: $1.11 million | Fiscal year 2018: $5.64 million | Fiscal year 2017: $6.32 million | Fiscal year 2016: $5.84 million | Fiscal year 2015: $4.96 million | Fiscal year 2014: $7.78 million | Fiscal year 2013: $39.38 million | Fiscal year 2012: $48.27 million | Fiscal year 2011: $17.81 million | Fiscal year 2010: $3.42 million | Fiscal year 2009: $6.45 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: